in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—19 August 2014
3:12 AM MDT | August 19, 2014 | Deepti Ramesh
Perrigo's API segment reports fall in sales and operating profits The active pharmaceutical ingredient (API) business segment of Perrigo (Dublin) reports a 20.5% fall in sales in the company’s fiscal fourth quarter ended 28 June 2014, compared with the year-ago period, to $32.5 million. Operating profits for the API segment decreased 12% in the quarter, to $8.8 million. The API segment's fourth-quarter sales declined due primarily to a $17-million decrease in sales of existing products as a result of increased competition on certain products, partially...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee